Transposition of the great vessels epidemiology and demographics

Transposition of the great vessels Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Dextro-transposition of the great arteries
L-transposition of the great arteries
Pathophysiology
Causes
Differentiating Transposition of the great vessels from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
MRI
CT
Echocardiography
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Palliative care
Corrective surgery
Post-operative care
Follow up
Prevention
Reproduction
Case Studies
Case #1
Transposition of the great vessels epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Transposition of the great vessels epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Transposition of the great vessels epidemiology and demographics
CDC on Transposition of the great vessels epidemiology and demographics
Transposition of the great vessels epidemiology and demographics in the news
Blogs on Transposition of the great vessels epidemiology and demographics
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Transposition of the great vessels epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

Transposition of the great arteries most commonly present within first 24 hours of life

Epidemiology and demographics

• Transposition of the great arteries TGA is one of the commonest cyanotic congenital heart defects present in the first 24 hours of life.
• An incidence at birth of 20-30 in 100000 live births
• TGA represents 5-7% of all CHD.
• Almost 20 percent of all cyanotic CHD defects
• TGA is more common in infants of diabetic mothers.
• Boys outnumber girls with an approximate ratio of 2:1.
• Without treatment, 30% of infants die within the first week of life, 50% will die in the first month, 70% will die in the first 6 months and 90% of infants will die before the end of the first year.